释放瘤生物学生物标志物的潜力:临床治疗学的进步
Ankit Kumar Dubey1,2, Ishnoor Kaur3, Reecha Madaan3
1Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, 34753 Sichuan University , Chengdu, P.R. China.
Drug metabolism and personalized therapy
|March 12, 2024
概括
癌症生物标志物正在彻底改变瘤学,为早期检测和个性化治疗提供精确的见解. 本综述强调了它们在改善患者治疗结果和通过新技术推进癌症护理方面的作用.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 分子诊断学 分子诊断学
背景情况:
- 癌症生物标志物为瘤生物学提供了关键的见解,有助于查,诊断,预后和治疗选择.
- "omic"技术的进步提高了生物标志物的可靠性和准确性,可以预测癌症治疗结果.
- 生物标志物为传统方法提供了一个有希望的替代方案,支持癌症治疗中的个性化/精确方法.
研究的目的:
- 审查生物标志物在癌症识别和表征中的临床实用性.
- 强调生物标志物对癌症查和早期发现的潜在贡献.
- 为了提供一个全面的概述生物标志物在推进瘤诊断和治疗的潜力.
主要方法:
- 文献综述侧重于癌症生物标志物的临床实用性和技术进步.
- 分析生物标志物在各种恶性瘤中的作用及其分子特征.
- 探索用于癌症治疗中的生物标志物开发和应用的新技术.
主要成果:
- 生物标志物对于了解恶性瘤的范围及其生物化学/分子概况至关重要.
- 生物标志物在早期癌症检测和预测疾病严重程度方面显著有前途.
- 该审查强调了生物标志物在改善生存率和降低死亡率方面的动态作用.
结论:
- 生物标志物是现代瘤学中不可或缺的工具,推动个性化医疗和改善患者护理.
- 在生物标志物发现领域的持续研究和技术创新将进一步加强癌症查,诊断和治疗.
- 生物标志物是实现有效癌症治疗和改善患者治疗结果的关键策略.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.7K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K